Metabolic Syndrome Increases Operative Mortality in Patients Undergoing Coronary Artery Bypass Grafting Surgery
Najmeddine Echahidi, MD*,
Philippe Pibarot, DVM, PhD, FACC, FAHA*,1,
Jean-Pierre Després, PhD, FAHA ,2,
Jean-Marc Daigle, MSc ,
Dania Mohty, MD*,4,
Pierre Voisine, MD||,
Richard Baillot, MD|| and
Patrick Mathieu, MD||,3,*
|| Department of Surgery, Centre de Recherche de l’Hôpital Laval/Institut de Cardiologie de Québec, Quebec, Canada
* Department of Medicine, Centre de Recherche de l’Hôpital Laval/Institut de Cardiologie de Québec, Quebec, Canada
Department of Social and Preventive Medicine, Centre de Recherche de l’Hôpital Laval/Institut de Cardiologie de Québec, Quebec, Canada
National Public Health Institute, Quebec, Canada.
View larger version (9K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 The Effect of the Number of Metabolic Syndrome Components on Operative Mortality Risk
The operative mortality risk was adjusted for age and gender, and the group with no component of the National Cholesterol Education Program–Adult Treatment Panel III (NCEP-ATPIII) was used as the referent.
|
|
View larger version (8K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Adjusted Relative Risk for Operative Mortality According to MS and Diabetes
The relative risk was adjusted for age and other covariates, and the group with no metabolic syndrome (MS) and no diabetes was used as the referent. The error bars represent the 95% confidence interval.
|
|
|
